Tumour inhibitory triazenes: structural requirements for an active metabolite.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003640:Dealkylation; D005260:Female; D006207:Half-Life; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008808:Mice, Inbred CBA; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013329:Structure-Activity Relationship; D014226:Triazenes / Q000378:metabolism / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014226:Triazenes